These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2999782)

  • 1. Lysine residue 121 in the proposed ATP-binding site of the v-mos protein is required for transformation.
    Hannink M; Donoghue DJ
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):7894-8. PubMed ID: 2999782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serine kinase activity associated with Maloney murine sarcoma virus-124-encoded p37mos.
    Maxwell SA; Arlinghaus RB
    Virology; 1985 May; 143(1):321-33. PubMed ID: 2998008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of site-specific antipeptide antibodies to perturb the serine kinase catalytic activity of p37mos.
    Maxwell SA; Arlinghaus RB
    J Virol; 1985 Sep; 55(3):874-6. PubMed ID: 2991608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p37mos-associated serine/threonine protein kinase activity correlates with the cellular transformation function of v-mos.
    Singh B; Hannink M; Donoghue DJ; Arlinghaus RB
    J Virol; 1986 Dec; 60(3):1148-52. PubMed ID: 3023666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the v-mos gene alters a Mr 55,000 protein during acute infection by Moloney murine sarcoma virus.
    Singh B; Sparrow JT; Hedge AM; Arlinghaus RB
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):3629-33. PubMed ID: 3012522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The histidine-221 to tyrosine substitution in v-mos abolishes its biological function and its protein kinase activity.
    Singh B; Wittenberg C; Hannink M; Reed SI; Donoghue DJ; Arlinghaus RB
    Virology; 1988 May; 164(1):114-20. PubMed ID: 2966489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. v-mos proteins encoded by myeloproliferative sarcoma virus and its ts159 mutant.
    Singh B; Stocking C; Walker R; Yang YD; Ostertag W; Arlinghaus RB
    J Virol; 1992 Feb; 66(2):1267-72. PubMed ID: 1309903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the mouse mammary tumor virus long terminal repeat to promote steroid-inducible expression of v-mos.
    Papkoff J; Ringold GM
    J Virol; 1984 Nov; 52(2):420-30. PubMed ID: 6092668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody detection of transformation associated protein (TAP) in ts110 Moloney murine sarcoma virus transformed 6M2 cells that are different from the mos gene product.
    Chan JC; Keck ME; Li W
    Biochem Biophys Res Commun; 1986 Feb; 134(3):1223-30. PubMed ID: 3004486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis underlying phenotypic revertants of Moloney murine sarcoma virus MuSVts110.
    Cizdziel PE; Nash MA; Blair DG; Murphy EC
    J Virol; 1986 Jan; 57(1):310-7. PubMed ID: 3001354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming mutant v-mos protein kinases that are deficient in in vitro autophosphorylation.
    Freeman RS; Donoghue DJ
    Mol Cell Biol; 1989 Sep; 9(9):4087-90. PubMed ID: 2528689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moloney murine sarcoma virus encoded p37mos expressed in yeast has protein kinase activity.
    Singh B; Wittenberg C; Reed SI; Arlinghaus RB
    Virology; 1986 Jul; 152(2):502-6. PubMed ID: 3014729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cAMP-independent serine/threonine kinase activity is associated with the mos sequences of ts110 Moloney murine sarcoma virus-encoded P85gag-mos.
    Maxwell SA; Arlinghaus RB
    J Gen Virol; 1985 Oct; 66 ( Pt 10)():2135-46. PubMed ID: 2995551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gag-mos hybrid protein of ts110 Moloney murine sarcoma virus: variation of gene expression with temperature.
    Gallick GE; Hamelin R; Maxwell S; Duyka D; Arlinghaus RB
    Virology; 1984 Dec; 139(2):366-74. PubMed ID: 6097031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further characterization of the P85gag-mos -associated protein kinase activity.
    Kloetzer WS; Maxwell SA; Arlinghaus RB
    Virology; 1984 Oct; 138(1):143-55. PubMed ID: 6093355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vimentin phosphorylation by p37mos protein kinase in vitro and generation of a 50-kDa cleavage product in v-mos-transformed cells.
    Singh B; Arlinghaus RB
    Virology; 1989 Nov; 173(1):144-56. PubMed ID: 2554568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of metal-induced mutations altering the expression or structure of a retroviral gene in a mammalian cell line.
    Biggart NW; Murphy EC
    Mutat Res; 1988 Mar; 198(1):115-29. PubMed ID: 2832750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor precursor is related to the translation product of the Moloney sarcoma virus oncogene mos.
    Baldwin GS
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):1921-5. PubMed ID: 2984673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of mos-related proteins with an antiserum to a peptide of the v-mos gene product.
    Gallick GE; Sparrow JT; Singh B; Maxwell SA; Stanker LH; Arlinghaus RB
    J Gen Virol; 1985 May; 66 ( Pt 5)():945-55. PubMed ID: 2987403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleotide sequence and biochemical activities of the Moloney murine sarcoma virus strain HT-1 mos gene.
    Seth A; Vande Woude GF
    J Virol; 1985 Oct; 56(1):144-52. PubMed ID: 2993645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.